Changing from lipoprotein apheresis to evolocumab treatment lowers circulating levels of arachidonic acid and oxylipins
Article in Atherosclerosis Plus (February 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Article in Atherosclerosis Plus (February 2024)
Preprint in bioRxiv (May 2023)
Article in PLOS ONE (January 2023)